Zhou Qiongjie, Zhao Xingzhong, Xu Jinghui, Xiong Yu, Barrett Jon F R, Zhao Xing-Ming, Li Xiaotian
Department of Obstetrics, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, China.
Front Cardiovasc Med. 2023 Jan 17;9:964541. doi: 10.3389/fcvm.2022.964541. eCollection 2022.
The use of low-dose aspirin for women with twin pregnancies remains controversial. This study was to describe the frequency of preeclampsia and aspirin use in twin pregnancies in real practice.
This retrospective cohort study based on real-world data was conducted in the Obstetrics and Gynecology Hospital of Fudan University between 2013 and 2020. Women with twin pregnancies who received prenatal care before 20 weeks of gestational age were included. They were divided into those using low-dose aspirin (LDA group) and those not using aspirin group (N-LDA group). The primary outcome was the frequency of preeclampsia, and secondary outcomes included early-onset and preterm mild and severe preeclampsia.
A total of 2,946 women had twin pregnancies, and 241 were excluded due to missing information. Of 2,705 eligible women, 291 (10.75%) were administered aspirin and the other 2,414 (89.25%) did not. The patients in the LDA group were significantly more likely to be older, have a higher rate of use of ART, have a previous history of hypertension, and have gestational diabetes ( < 0.05). In the LDA group, aspirin compliance ≥50% was relatively low (14.43%, 42/291). Preeclampsia occurred in 106 of 291 participants (36.43%) in the LDA group, as compared to 449 of 2,411 (18.62%) in the N-LDA group (OR: 2.15, 95% CI: 1.62-2.82; < 0.01). The association was confirmed (OR: 1.74, 95% CI: 1.26-2.4; < 0.01) in the 1:2 case-matched analysis. Higher odds of ratio in the LDA group were demonstrated (aORs > 1, < 0.01), except for early-onset and preterm mild preeclampsia ( > 0.05). This association was confirmed in a subgroup analysis of methods of conception (aORs ≥ 1, > 0.05).
Aspirin prescription of 75 to 100 mg in twin pregnancies was associated with no significant reduction of preeclampsia, which may be due to poor compliance with the aspirin used. Further randomized controlled or prospective cohort studies are required.
低剂量阿司匹林在双胎妊娠女性中的应用仍存在争议。本研究旨在描述实际临床中双胎妊娠子痫前期的发生频率及阿司匹林的使用情况。
本回顾性队列研究基于真实世界数据,于2013年至2020年在复旦大学附属妇产科医院开展。纳入孕20周前接受产前检查的双胎妊娠女性。她们被分为使用低剂量阿司匹林组(LDA组)和未使用阿司匹林组(N-LDA组)。主要结局是子痫前期的发生频率,次要结局包括早发型和早产型轻度及重度子痫前期。
共有2946名女性为双胎妊娠,241名因信息缺失被排除。在2705名符合条件的女性中,291名(10.75%)使用了阿司匹林,另外2414名(89.25%)未使用。LDA组患者年龄显著更大,辅助生殖技术使用率更高,既往有高血压病史和妊娠期糖尿病的比例更高(P<0.05)。在LDA组中,阿司匹林依从性≥50%的比例相对较低(14.43%,42/291)。LDA组291名参与者中有106名(36.43%)发生子痫前期,而N-LDA组2411名中有449名(18.62%)发生子痫前期(OR:2.15,95%CI:1.62 - 2.82;P<0.01)。在1:2病例匹配分析中该关联得到证实(OR:1.74,95%CI:1.26 - 2.4;P<0.01)。除早发型和早产型轻度子痫前期外(P>0.05),LDA组的比值比更高(调整后OR>1,P<0.01)。在受孕方式的亚组分析中该关联得到证实(调整后OR≥1,P>0.05)。
双胎妊娠中75至100毫克阿司匹林的处方与子痫前期无显著降低相关,这可能是由于阿司匹林使用依从性差所致。需要进一步开展随机对照或前瞻性队列研究。